Thomas E.  Roos net worth and biography

Thomas Roos Biography and Net Worth

Thomas E. Roos is Senior Vice President, Chief Accounting Officer of the Company. Mr. Roos is Senior Vice President and Chief Accounting Officer of UnitedHealth Group and has served in that capacity since August 2015. Prior to joining UnitedHealth Group, Mr. Roos was a Partner at Deloitte & Touche LLP, an independent registered accounting firm, from September 2007 to August 2015.

What is Thomas E. Roos' net worth?

The estimated net worth of Thomas E. Roos is at least $17.72 million as of July 17th, 2024. Mr. Roos owns 29,501 shares of UnitedHealth Group stock worth more than $17,715,351 as of November 21st. This net worth evaluation does not reflect any other investments that Mr. Roos may own. Learn More about Thomas E. Roos' net worth.

How old is Thomas E. Roos?

Mr. Roos is currently 51 years old. There are 6 older executives and no younger executives at UnitedHealth Group. The oldest executive at UnitedHealth Group is Mr. James T. Barry Jr., Director of Sales for Western Pennsylvania, who is 78 years old. Learn More on Thomas E. Roos' age.

How do I contact Thomas E. Roos?

The corporate mailing address for Mr. Roos and other UnitedHealth Group executives is 9900 BREN ROAD EAST, MINNETONKA MN, 55343. UnitedHealth Group can also be reached via phone at (952) 936-1300 and via email at [email protected]. Learn More on Thomas E. Roos' contact information.

Has Thomas E. Roos been buying or selling shares of UnitedHealth Group?

Thomas E. Roos has not been actively trading shares of UnitedHealth Group over the course of the past ninety days. Most recently, Thomas E. Roos sold 2,851 shares of the business's stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a transaction totalling $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares of the company's stock, valued at $16,812,029.88. Learn More on Thomas E. Roos' trading history.

Who are UnitedHealth Group's active insiders?

UnitedHealth Group's insider roster includes Richard Burke (Director), Paul Garcia (Director), Stephen Hemsley (Director), Patricia Lewis (EVP), Dirk McMahon (Pres & COO ), Dirk McMahon (CEO), Frederick McNabb, III (Director), Erin Mcsweeney (EVP), Steven Nelson (CEO), Larry Renfro (Insider), John Rex (CFO), Thomas Roos (CAO), Marianne Short (EVP), Brian Thompson (Exec. VP & CEO of UnitedHealthcare), David Wichmann (CEO), D. Wilson (EVP), and Andrew Witty (CEO). Learn More on UnitedHealth Group's active insiders.

Are insiders buying or selling shares of UnitedHealth Group?

During the last twelve months, insiders at the healthcare conglomerate sold shares 5 times. They sold a total of 72,526 shares worth more than $39,912,303.57. The most recent insider tranaction occured on July, 18th when EVP Erin Mcsweeney sold 1,500 shares worth more than $868,545.00. Insiders at UnitedHealth Group own 0.3% of the company. Learn More about insider trades at UnitedHealth Group.

Information on this page was last updated on 7/18/2024.

Thomas E. Roos Insider Trading History at UnitedHealth Group

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/17/2024Sell2,851$569.88$1,624,727.8829,501View SEC Filing Icon  
2/23/2024Sell858$525.79$451,127.8232,289View SEC Filing Icon  
8/26/2022Sell465$542.37$252,202.0534,786View SEC Filing Icon  
4/27/2021Sell5,301$394.66$2,092,092.6658,589View SEC Filing Icon  
2/9/2021Sell619$323.90$200,494.1031,908View SEC Filing Icon  
11/7/2019Sell1,177$255.04$300,182.0821,687View SEC Filing Icon  
10/19/2017Sell975$205.47$200,333.2524,630View SEC Filing Icon  
See Full Table

Thomas E. Roos Buying and Selling Activity at UnitedHealth Group

This chart shows Thomas E Roos's buying and selling at UnitedHealth Group by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

UnitedHealth Group Company Overview

UnitedHealth Group logo
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.
Read More

Today's Range

Now: $600.50
Low: $581.55
High: $602.64

50 Day Range

MA: $582.52
Low: $554.45
High: $625.25

2 Week Range

Now: $600.50
Low: $436.38
High: $630.73

Volume

3,921,374 shs

Average Volume

3,114,626 shs

Market Capitalization

$552.63 billion

P/E Ratio

39.12

Dividend Yield

1.46%

Beta

0.58